https://www.selleckchem.com/products/c381.html
47) and "Age" (p = 0.18) factors. However, there were significant differences in "Physiology" factors (% of forced vital capacity, p = 0.018; % of diffusing capacity of lung carbon monoxide, p 0.001). The cumulative incidences of mortality at 1 and 2 years were as follows GAP I 5.1% and 6.8%; GAP II 9.5% and 29.3%; and GAP III 18.9% and 84.2%. The GAP system is useful as a prognostic tool in patients with IPF who have been treated with nintedanib. The GAP system is useful as a prognostic tool in patients with IPF who have been treated
Like
Comment
Share
